Company Overview
Wearable Devices Ltd. is a technology firm dedicated to the development of a non-invasive neural input interface designed to control digital devices through subtle touchless finger movements. The company operates within the broader technology sector, specifically focusing on the consumer electronics industry where innovation in user interface technology is paramount. As of the latest available data, the company holds a market capitalization of $4.46M and reports an annual revenue of $647,000 over the trailing twelve months. With an employee count listed as N/A, the firm presents a highly specialized profile typical of early-stage development entities. The relatively low market cap combined with the modest revenue figure indicates that the company is currently operating on a small scale, likely concentrating resources on product development rather than widespread commercial distribution or market dominance. This valuation suggests the market is pricing the stock based on potential future utility of the neural interface technology rather than current operational cash flows or established market share.
Financial Health
The company reported a revenue of $647,000 for the trailing twelve months, while simultaneously posting a net income loss of $-8,107,000 and an EBITDA of $-8,248,000. The significant disparity between the positive revenue figure and the substantial negative net income reveals a cost structure where operating expenses vastly outweigh the income generated from sales, a common characteristic in high-research-and-development phases. Free cash flow stands at $-3,558,500, indicating that the company is currently burning cash to fund its operations and development efforts rather than generating surplus liquidity. The gross margin is recorded at -22.9%, reflecting costs of goods sold that exceed revenue, while the operating margin is a severe -1295.8% and profit margin is 0.0%, highlighting extreme operational inefficiency or heavy investment in non-revenue-generating activities relative to sales. Despite these negative earnings metrics, the company holds a significant cash reserve of $18.42M, which is more than forty times its total debt of $366,000. The debt-to-equity ratio is 1.97, yet the massive cash balance suggests the balance sheet is not leveraged in a distressed manner but rather funded primarily by equity and cash reserves. The current ratio is an exceptionally high 14.15, indicating that the company possesses ample short-term assets to cover its short-term liabilities, providing a strong buffer against immediate liquidity crises. Return on equity is -72.3% and return on assets is -40.1%, metrics that reveal that management is currently utilizing shareholder and asset bases to generate losses rather than positive returns, a typical scenario for a company in the pre-profitability stage.
Valuation Assessment
The trailing twelve-month P/E ratio is N/A due to the negative earnings, and the forward P/E is also N/A, implying that traditional earnings-based valuation methods cannot currently be applied to assess the stock's trajectory. The price-to-book ratio is 0.19, which indicates that the market values the company at less than one-fifth of its book value, suggesting investors are pricing in significant risks or expecting a long path to profitability. The price-to-sales ratio stands at 6.90, while the EV/EBITDA multiple is 1.76; these alternative metrics suggest that the market is valuing the company based on its sales potential and enterprise value relative to earnings before interest, taxes, depreciation, and amortization, despite the current losses. The stock's 52-week high is $34.20 and the 52-week low is $1.24, a range that illustrates significant price volatility and investor sentiment swings over the past year. The current price sits well below the 52-week high of $34.20, reflecting a significant pullback from the peak valuation levels observed during the period. The beta value is 3.79, which means the stock price is expected to be nearly four times more volatile than the broader market, exposing investors to substantial price swings during periods of market turbulence.
Growth & Income
Revenue growth year-over-year is 175.8%, demonstrating a rapid expansion in top-line sales, whereas earnings growth is N/A due to the absence of positive net income in the current period. The divergence between high revenue growth and negative earnings indicates that the company is prioritizing top-line expansion and likely heavy investment in growth initiatives over immediate profitability. The dividend yield is N/A and the payout ratio is 0.0%, confirming that the company does not distribute dividends to shareholders. Instead of paying out income, the company reinvests its earnings—specifically its substantial cash reserves—into research, development, and operational scaling to potentially achieve future profitability. This growth and income profile characterizes a high-risk, high-potential venture that offers no current income distribution but provides significant upside potential if the underlying neural interface technology achieves commercial success and cost efficiencies.